How should spirometry results showing a forced vital capacity of 80% predicted, a forced expiratory volume in one second of 0.37 L, and an FEV1/FVC ratio of 0.13 be interpreted and managed?

Severe Obstructive Lung Disease Requiring Immediate Clinical Action

These spirometry results demonstrate severe obstructive lung disease with an FEV1/FVC ratio of 0.13 (13%), which is markedly below the diagnostic threshold of 0.70 (70%), and an extremely low FEV1 of 0.37 L, indicating GOLD Grade 4 (very severe) airflow obstruction if this represents COPD. 1

Interpretation Algorithm

Step 1: Confirm Obstruction Pattern

• FEV1/FVC ratio = 0.13 → Severely reduced (normal ≥0.70)
• This unequivocally confirms severe airflow obstruction 1
• The FVC at 80% predicted is relatively preserved, which is typical in obstructive disease where the ratio drops disproportionately

Step 2: Assess Severity

• FEV1 = 0.37 L → This absolute value is critically low
• If this represents <30% predicted, this classifies as GOLD Grade 4 (very severe) obstruction
• If 30-49% predicted, this is GOLD Grade 3 (severe) obstruction
• Either classification carries significant mortality and morbidity implications 2

Step 3: Critical Next Actions

Immediate bronchodilator testing is essential to:

• Assess reversibility (≥12% AND ≥200 mL improvement in FEV1 or FVC in adults) 2, 3
• Differentiate COPD from asthma, though this distinction is imperfect even post-bronchodilator 3
• Guide therapeutic decisions, as volume responses may occur without flow responses in severe disease 1

Important caveat: In severe COPD (GOLD Grade 4), flow responses typically decrease while volume responses may predominate, potentially causing the FEV1/FVC ratio to decrease further post-bronchodilator rather than improve 1

Clinical Management Priorities

Mortality and Morbidity Considerations

With an FEV1 this low, the patient faces:

• High risk of respiratory failure
• Increased mortality risk
• Severe exercise limitation and quality of life impairment
• High risk of exacerbations requiring hospitalization

Essential Workup

1. Post-bronchodilator spirometry (if not already done)
2. Full pulmonary function testing including lung volumes to assess:
   • Total lung capacity (TLC) for hyperinflation
   • Residual volume (RV) for gas trapping
   • Diffusing capacity (DLCO) for emphysema assessment
3. Arterial blood gas to evaluate for hypoxemia and hypercapnia
4. Chest imaging (CT preferred over plain radiograph) to identify structural disease

Consider Alternative Diagnoses

While COPD is most likely, this severity warrants excluding:

• Severe asthma (check for reversibility)
• Bronchiectasis
• Obliterative bronchiolitis
• Advanced interstitial lung disease with obstructive component

Common Pitfalls to Avoid

Do not rely solely on FEV1/FVC ratio: The GOLD 2025 guidelines acknowledge that if clinical suspicion is high but spirometry seems discordant, consider measuring FEV1/SVC (slow vital capacity) ratio, as FVC may underestimate true vital capacity in severe small airway disease 1

Do not assume irreversibility: Even with severe obstruction, 23% of COPD patients show significant volume responses to bronchodilators, which impacts treatment decisions 1

Do not delay oxygen assessment: With FEV1 this low, supplemental oxygen may be life-saving if hypoxemia is present

Verify test quality: Ensure the spirometry was performed correctly with adequate effort and technique, as poor technique can artificially lower values